Open PHACTS API 1.3 released
We are excited to release the Open PHACTS API 1.3. Among the features are: Over 2,900 million triples New compound API calls: drug type (approved, experimental) New pharmacology API calls: pChEMBL, assay type, generic name, literature DOI/PMID, target type and component New target info API calls: ChEMBL URIs, UniProt protein-protein interactions,…
Publication: Applying Linked Data Approaches to Pharmacology: Architectural Decisions and Implementation
The discovery of new medicines requires pharmacologists to interact with a number of information sources ranging from tabular data to scientific papers, and other specialized formats. In this application report, we describe a linked data platform for integrating multiple pharmacology datasets that form the basis for several drug discovery applications….
The Open PHACTS Foundation joins the project
We are pleased to announce that the Open PHACTS project’s successor organisation, the Open PHACTS Foundation, has joined the project as a partner. The Open PHACTS Foundation aims to ensure the sustainability of the Open PHACTS Discovery Platform infrastructure. Furthermore, it acts as a hub for scientific research and development relevant…
Conference: 5th Annual aDREAM Conference
5th Development of Robust Experimental Assay Methods (aDREAM) Conference, Madison, USA Linda Zander-Balderud (AstraZeneca) gave a presentation: Applying BioAssay Ontology to facilitate HTS analysis
Presentation: Applying BioAssay Ontology to facilitate HTS analysis
5th Development of Robust Experimental Assay Methods (aDREAM) Conference, Madison, USA Linda Zander-Balderud (AstraZeneca) View presentation